Bader Alahmari

632 total citations
38 papers, 343 citations indexed

About

Bader Alahmari is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Bader Alahmari has authored 38 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hematology, 17 papers in Genetics and 9 papers in Oncology. Recurrent topics in Bader Alahmari's work include Hemoglobinopathies and Related Disorders (10 papers), Hematopoietic Stem Cell Transplantation (9 papers) and Acute Myeloid Leukemia Research (7 papers). Bader Alahmari is often cited by papers focused on Hemoglobinopathies and Related Disorders (10 papers), Hematopoietic Stem Cell Transplantation (9 papers) and Acute Myeloid Leukemia Research (7 papers). Bader Alahmari collaborates with scholars based in Saudi Arabia, United States and Lebanon. Bader Alahmari's co-authors include Jaebok Choi, Matthew Cooper, John F. DiPersio, Julie Ritchey, Lynne Collins, Matthew Holt, Mohsen Alzahrani, Moussab Damlaj, Ahmed Alaskar and Samuel Achilefu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Bader Alahmari

32 papers receiving 342 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bader Alahmari Saudi Arabia 8 209 110 107 75 43 38 343
Léonardo Magro France 11 270 1.3× 105 1.0× 116 1.1× 119 1.6× 75 1.7× 43 469
Kun Soo Lee South Korea 12 287 1.4× 126 1.1× 60 0.6× 98 1.3× 70 1.6× 43 449
Priscila Scheinberg United States 6 464 2.2× 150 1.4× 110 1.0× 134 1.8× 27 0.6× 8 534
Marguerite Vignon France 10 114 0.5× 102 0.9× 68 0.6× 74 1.0× 90 2.1× 26 324
Fleur Samantha Benghiat Belgium 11 172 0.8× 178 1.6× 180 1.7× 28 0.4× 58 1.3× 29 435
Sergey N. Bondarenko Russia 9 335 1.6× 144 1.3× 62 0.6× 112 1.5× 54 1.3× 117 466
A. Ferster Belgium 9 232 1.1× 92 0.8× 51 0.5× 76 1.0× 65 1.5× 11 370
Muthalagu Ramanathan United States 11 243 1.2× 102 0.9× 41 0.4× 103 1.4× 66 1.5× 53 390
László Gopcsa Hungary 13 132 0.6× 100 0.9× 53 0.5× 92 1.2× 79 1.8× 44 339
Minako Iida Japan 7 290 1.4× 105 1.0× 78 0.7× 102 1.4× 80 1.9× 13 436

Countries citing papers authored by Bader Alahmari

Since Specialization
Citations

This map shows the geographic impact of Bader Alahmari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bader Alahmari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bader Alahmari more than expected).

Fields of papers citing papers by Bader Alahmari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bader Alahmari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bader Alahmari. The network helps show where Bader Alahmari may publish in the future.

Co-authorship network of co-authors of Bader Alahmari

This figure shows the co-authorship network connecting the top 25 collaborators of Bader Alahmari. A scholar is included among the top collaborators of Bader Alahmari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bader Alahmari. Bader Alahmari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Alzahrani, Mohsen, et al.. (2024). Outcome of Respiratory Viral Infections in Hematopoietic Stem Cell Transplant Recipients. Transplantation Proceedings. 56(1). 186–190.
4.
Alghamdi, Ali, et al.. (2023). Improved Quality of Life of Patients With Sickle Cell Disease after Allogeneic Stem Cell Transplant: Another Indication for Transplant. Hematology/Oncology and Stem Cell Therapy. 17(1). 37–42. 2 indexed citations
5.
Shaheen, Naila, et al.. (2022). Incidence of ocular manifestations in patients with graft versus host disease after allogeneic stem cell transplant in Riyadh, Saudi Arabia. International Journal of Ophthalmology. 15(7). 1149–1156. 6 indexed citations
6.
7.
8.
Abuelgasim, Khadega A., et al.. (2021). Impact of cluster of differentiation 20 expression and rituximab therapy in classical Hodgkin lymphoma: Real world experience. SHILAP Revista de lepidopterología. 15. 100240–100240. 5 indexed citations
9.
10.
Damlaj, Moussab, Farhan Khalid, Bader Alahmari, et al.. (2020). Optimal pre-emptive cytomegalovirus therapy threshold in a patient population with high prevalence of seropositive status. Current Research in Translational Medicine. 68(3). 131–137. 5 indexed citations
11.
Jazieh, Abdul Rahman, Mohsen Alzahrani, Ahmed Alaskar, et al.. (2020). Highlights of the Management of Adult Histiocytic Disorders: Langerhans Cell Histiocytosis, Erdheim-Chester Disease, Rosai-Dorfman Disease, and Hemophagocytic Lymphohistiocytosis. Clinical Lymphoma Myeloma & Leukemia. 21(1). e66–e75. 20 indexed citations
12.
Damlaj, Moussab, et al.. (2019). Therapeutic Potential of Checkpoint Inhibitors in Refractory Plasmablastic Lymphoma. Clinical Lymphoma Myeloma & Leukemia. 19(10). e559–e563. 8 indexed citations
13.
Choi, Jaebok, Matthew Cooper, Karl Staser, et al.. (2018). Baricitinib-induced blockade of interferon gamma receptor and interleukin-6 receptor for the prevention and treatment of graft-versus-host disease. Leukemia. 32(11). 2483–2494. 66 indexed citations
14.
Damlaj, Moussab, et al.. (2018). Graft vs host disease impacts overall survival post allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia/lymphoma. World Journal of Transplantation. 8(7). 252–261. 3 indexed citations
15.
Alahmari, Bader, et al.. (2018). Selective targeting of histone modification fails to prevent graft versus host disease after hematopoietic cell transplantation. PLoS ONE. 13(11). e0207609–e0207609. 6 indexed citations
16.
Damlaj, Moussab, Mohsen Alzahrani, Ghulam Syed, et al.. (2018). Interim Functional Imaging Is an Independent Predictor of Progression-free Survival in Advanced Classical Hodgkin Lymphoma – A Real-world Analysis. Clinical Lymphoma Myeloma & Leukemia. 19(1). e71–e79. 4 indexed citations
17.
18.
Alzahrani, Mohsen, Ahmed Alaskar, Moussab Damlaj, et al.. (2017). Non-Myeloablative Transplant in Severe Sickle Cell Disease Is Safe & Effective. Single Center Experience from Saudi Arabia. Blood. 130. 5549–5549. 1 indexed citations
19.
Choi, Jaebok, Matthew Cooper, Kiran Vij, et al.. (2016). Pharmacologic Co-Blockade of IFNγR and IL6R Pathways to Prevent and Treat GvHD. Blood. 128(22). 3353–3353. 3 indexed citations
20.
Choi, Jaebok, Matthew Cooper, Bader Alahmari, et al.. (2014). Pharmacologic Blockade of JAK1/JAK2 Reduces GvHD and Preserves the Graft-Versus-Leukemia Effect. PLoS ONE. 9(10). e109799–e109799. 117 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Léonardo Magro Breakdown of academic impact, for papers by Kun Soo Lee Breakdown of academic impact, for papers by Priscila Scheinberg Breakdown of academic impact, for papers by Marguerite Vignon Breakdown of academic impact, for papers by Fleur Samantha Benghiat Breakdown of academic impact, for papers by Sergey N. Bondarenko Breakdown of academic impact, for papers by A. Ferster Breakdown of academic impact, for papers by Muthalagu Ramanathan Breakdown of academic impact, for papers by László Gopcsa Breakdown of academic impact, for papers by Minako Iida
Rankless by CCL
2026